U.S., Sept. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07829302) titled 'VV-14299 and VV-14300 for the Treatment of Type 1 Diabetes' on Aug. 31.
Brief Summary: This study is testing VV-14299 and VV-14300 or VV-14300 alone in adults with long-standing type 1 diabetes (T1D) whose blood sugar is not well controlled despite using an automated insulin delivery (AID) system. VV-14299 and VV-14300 are investigational gene therapies that are injected into muscle and are designed to work together to help remove excess sugar from the blood.
Study Start Date: Sept., 2026
Study Type: INTERVENTIONAL
Condition:
Type 1 Diabetes Mellitus
Intervention:
GENETIC: VV-14300
VV-14300 will be administered via ultrasoun...